Mustang Bio, Inc. (NASDAQ:MBIO – Get Free Report) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 136,500 shares, a drop of 23.3% from the March 31st total of 178,000 shares. Based on an average daily volume of 204,000 shares, the days-to-cover ratio […]
Mustang Bio (NASDAQ:MBIO – Get Free Report) and Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk. Valuation and Earnings This table compares […]
Mustang Bio (NASDAQ:MBIO – Get Free Report) is scheduled to be posting its quarterly earnings results on Tuesday, November 14th. Mustang Bio (NASDAQ:MBIO – Get Free Report) last posted its quarterly earnings data on Monday, August 14th. The company reported ($2.00) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.07) by […]
Mustang Bio (NASDAQ:MBIO – Get Free Report) will announce its earnings results on Tuesday, November 14th. Mustang Bio (NASDAQ:MBIO – Get Free Report) last issued its quarterly earnings results on Monday, August 14th. The company reported ($2.00) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.07) by $0.07. On average, analysts […]